Don’t miss the latest developments in business and finance.

Alembic Pharmaceuticals gets ANDA approval for Olmesartan Medoxomil and Amlodipine Tablets

Image
Capital Market
Last Updated : Jul 19 2017 | 12:02 AM IST

From USFDA

Alembic Pharmaceuticals has received US Food & Drug Administration (USFDA) Approval for Olmesartan Medoxomil and Amlodipine Tablets, 20mg/5mg, 40mg/5mg, 20mg/10mg and 40mg/10mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Azor Tablets, 20mg/5mg, 40mg/5mg, 20mg/10mg and 40mg/10mg of Daiichi Sankyo Inc. and is indicated in the treatment of hypertension.

Powered by Capital Market - Live News

Also Read

First Published: Jul 18 2017 | 12:48 PM IST

Next Story